Cargando…
Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants
Emerging SARS-CoV-2 variants have accrued mutations within the spike protein rendering most therapeutic monoclonal antibodies against COVID-19 ineffective. Hence there is an unmet need for broad-spectrum mAb treatments for COVID-19 that are more resistant to antigenically drifted SARS-CoV-2 variants...
Autores principales: | Du, Wenjuan, Janssens, Rick, Mykytyn, Anna Z., Li, Wentao, Drabek, Dubravka, van Haperen, Rien, Chatziandreou, Marianthi, Rissmann, Melanie, van der Lee, Joline, van Dortmondt, Melissa, Martin, Itziar Serna, van Kuppeveld, Frank J. M., Hurdiss, Daniel L., Haagmans, Bart L., Grosveld, Frank, Bosch, Berend-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990171/ https://www.ncbi.nlm.nih.gov/pubmed/36895554 http://dx.doi.org/10.3389/fimmu.2023.1111385 |
Ejemplares similares
-
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020) -
A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020) -
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
por: Wang, Chunyan, et al.
Publicado: (2021) -
Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes
por: Wang, Chunyan, et al.
Publicado: (2022) -
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
por: Widjaja, Ivy, et al.
Publicado: (2019)